Today we address a topic concerning a by no means small group of patients – an estimated 500 to 1,000 patients a year in Poland.
Patients with advanced gastric cancer (including metastatic disease) in poor general condition are not eligible for palliative chemotherapy and are usually advised to receive active symptomatic treatment, with an expected median survival of about 3 months. In other words, the ordeal of waiting for the inevitable. If we search the medical literature, we find that some authors recommend palliative radiotherapy for this group of patients, as it reduces symptoms such as difficulty swallowing and prolongs life. Read more on the oncology blog (in Polish).
If you need help, book an appointment at the Radiation Oncology Clinic.